SlideShare une entreprise Scribd logo
1  sur  42
kasr al ainy school of Medicine Cairo University   CHANGING ATTITUDES IN OVARIAN STIMULATION
CHANGING ATTITUDE IS A FACT OF LIFE ,[object Object],[object Object]
THE BEST MODEL  ,[object Object]
WHAT ABOUT GYNECOLOGY ,[object Object]
IVF ,[object Object]
16 follicles 12 mature oocytes 14 oocytes Extras frozen if good 2 to 3 transferred 9 fertilize normally 5 divide normally 30-40% of couples 4 stop dividing & sperm Typical progression
OHSS is the most serious complication  of ovulation induction.
PROTOCOLS FOR IVF  GnRH Antagonist Protocols GnRH  Agonist Protocols   225 IU per day (150 IU Europe ) Individualized Dosing of FSH/HMG 250 mg per day antagonist Individualized Dosing of FSH/HMG GnRHa 1.0 mg per day  up to 21 days 0.5 mg per day of GnRHa 225 IU per day (150 IU Europe ) Day 6 of  FSH/HMG Day of  hCG Day 1  of FSH/HMG Day 6 of  FSH/HMG Day of hCG 7 – 8 days after estimated ovulation Down regulation Day 2 or 3 of menses Day 1  FSH/HMG
SHOULD BE EVIDENCE BASED ,[object Object],[object Object]
AL-INANY & ABOULGHAR, 2001
AL-INANY ET AL., 2006  ,[object Object]
AL-INANY  ET AL., 2010 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IT IS JUSTIFIED TO ,[object Object]
WHY:  (AL-INANY ET AL, 2010)
HOW TO EXPLAIN ,[object Object],[object Object],[object Object],[object Object],[object Object]
NUMBER NEEDED TO HARM ,[object Object],[object Object]
CANCELLATION FOR RISK OF OHSS
CONSIDERING CYCLES CANCELLED FOR RISK OF OHSS ,[object Object],[object Object]
[object Object]
LIVE BIRTH RATE
CPR
MISCARRIAGE RATE
IN FAVOR OF ANTAGONIST ,[object Object],[object Object],[object Object]
3. 0  ampoules less with GnRH antagonists p<0.0 7   FSH requirement
1. 1  less days with antagonists p<0.001 Duration of FSH treatment
HOW TO EXPLAIN IMPROVED EFFICACY ,[object Object]
LH STABILITY: AGONIST VS. ANATGONIST
FIXED DOSE PROTOCOL
Flexible antagonist stimulation
Meta-analysis of clinical pregnancy rate in fixed and flexible protocols for GnRH antagonist protocols Al-Inany et al. 2005
FURTHER ANALYSIS ,[object Object],[object Object],[object Object],[object Object]
SO OUR CONCLUSION:  ,[object Object]
BUT NOT ALL DOCTORS WOULD GO FOR ANTAGONIST
(GNRH) ANTAGONISTS: OFF LABEL INDICATION  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VALUE ,[object Object]
 
OUR RESULTS Parameter Coasting (n = 96) Antagonist (n = 94) P-value Age (years) 30.0 ± 4.9 29.6 ± 4.6 NS Duration of infertility (years) 6.64 ± 4.45 7.07 ± 4.3 NS No. of HMG injections 30.52 ± 8.9 29.94 ± 8.8 NS Days of stimulation 1 9.1 ± 1.5 9.4 ± 1.5 NS Peak oestradiol (pg/ml) 5087 ± 1589 5305 ± 1680 NS Oestradiol on day of HCG (pg/ml) 2605 ± 790 2721 ± 699 NS Range of oestradiol on day of HCG (pg/ml)  1110–4136 1223–4093 NS Day of intervention 2.82 ± 0.97 1.74 ± 0.91 <0.0001 No. of oocytes 14.06 ± 5.20 16.5 ± 7.60 0.02 No. of MII oocytes  11.13 ± 4.60 13.14 ± 6.60 NS No. of fertilized oocytes    7.97 ± 3.80    9.14 ± 4.70 NS No. of high quality embryos    2.21 ± 1.10    2.87 ± 1.20 0.0001 No. of embryos transferred    2.83 ± 0.50    2.79 ± 0.40 NS No. of cryopreserved embryos    4.50 ± 3.93    5.77 ± 4.87 NS Clinical pregnancy (%) 46/96  (47.9) 52/94  (55.3) NS Multiple pregnancy (%) 15/46 (32.6) 17/52 (32.7) NS
THE FUTURE  ,[object Object],[object Object]
JUST A QUESTION ,[object Object]
SIMPLE, SHORTER  SAFER
WHY CHANGING ATTITUDE  ,[object Object],[object Object]
THANK YOU Dr. Hesham Al-Inany  MD, PhD e-mail : hesham@khosoba.com

Contenu connexe

Tendances

Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Ovarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarOvarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarLifecare Centre
 
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANIOVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Agonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulationAgonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulationSandro Esteves
 
Individualizing Ovarian Stimulation Protocols for IVF
Individualizing Ovarian Stimulation Protocols for IVFIndividualizing Ovarian Stimulation Protocols for IVF
Individualizing Ovarian Stimulation Protocols for IVFSherInstitute
 
what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?Aboubakr Elnashar
 
Controlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFAboubakr Elnashar
 
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...Lifecare Centre
 
Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Poonam Loomba
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIBharati Dhorepatil
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUISujoy Dasgupta
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation ProtocolsHesham Gaber
 
Recent advances in stimulation protocols
Recent advances in stimulation protocolsRecent advances in stimulation protocols
Recent advances in stimulation protocolsSandro Esteves
 
Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Lifecare Centre
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Lifecare Centre
 

Tendances (20)

Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Ovarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarOvarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
 
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANIOVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
OVULATION INDUCTION FOR IUI BY DR SHASHWAT JANI
 
Agonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulationAgonists and antagonists in controlled ovarian stimulation
Agonists and antagonists in controlled ovarian stimulation
 
Treatment of decreased ovarian reserve
Treatment of decreased ovarian reserveTreatment of decreased ovarian reserve
Treatment of decreased ovarian reserve
 
Individualizing Ovarian Stimulation Protocols for IVF
Individualizing Ovarian Stimulation Protocols for IVFIndividualizing Ovarian Stimulation Protocols for IVF
Individualizing Ovarian Stimulation Protocols for IVF
 
what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?what is new in controlled ovarian stimulation?
what is new in controlled ovarian stimulation?
 
Controlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVFControlled ovarian stimulation in IVF
Controlled ovarian stimulation in IVF
 
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
 
Management of thin endometrium isar 2019
Management of thin endometrium isar 2019Management of thin endometrium isar 2019
Management of thin endometrium isar 2019
 
Ovulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
 
Endometriosis and art
Endometriosis and artEndometriosis and art
Endometriosis and art
 
Difficult Cases in IUI
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
 
EMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROMEEMPTY FOLLICLE SYNDROME
EMPTY FOLLICLE SYNDROME
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
 
Recent advances in stimulation protocols
Recent advances in stimulation protocolsRecent advances in stimulation protocols
Recent advances in stimulation protocols
 
Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
 

En vedette

GnRH Agonists & Antagonists
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & AntagonistsManas Nath
 
GnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeGnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeSandro Esteves
 
GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?DrRitu Santwani
 
Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Nazmul Ahmed Oli
 
Optimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ARTOptimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ARTSandro Esteves
 
Antagonist or agonist
Antagonist or agonistAntagonist or agonist
Antagonist or agonistSantosh Gupta
 
LH in Human Reproduction
LH in Human ReproductionLH in Human Reproduction
LH in Human ReproductionSandro Esteves
 
Managing Difficult Infertile Patients
Managing Difficult Infertile PatientsManaging Difficult Infertile Patients
Managing Difficult Infertile PatientsDr Aniruddha Malpani
 
Individualization
IndividualizationIndividualization
Individualizationt7260678
 
C.1 menstrual cycle
C.1   menstrual cycleC.1   menstrual cycle
C.1 menstrual cycleserenaasya
 
Physiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in laborPhysiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in laborberbets
 
R lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cyclesR lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cyclesAlfredo Nazzaro
 
Vitrification in IVF
Vitrification in IVFVitrification in IVF
Vitrification in IVFG A RAMA Raju
 
Abortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, mdAbortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, mdLiza Tarca
 
Tema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bisTema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bisslayerail
 
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
 IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha... IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha...
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...Lifecare Centre
 
Individualization of Patient Treatment
Individualization of Patient TreatmentIndividualization of Patient Treatment
Individualization of Patient TreatmentSandro Esteves
 

En vedette (20)

GnRH Agonists & Antagonists
GnRH Agonists & AntagonistsGnRH Agonists & Antagonists
GnRH Agonists & Antagonists
 
GnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcomeGnRH agonist versus antagonist and impact on cycle outcome
GnRH agonist versus antagonist and impact on cycle outcome
 
GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?GnRH Agonist vs GnRH Antagonist what to choose?
GnRH Agonist vs GnRH Antagonist what to choose?
 
Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)Gonadotropin Releasing Hormone (GnRH)
Gonadotropin Releasing Hormone (GnRH)
 
Optimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ARTOptimizing Treatment Outcome in ART
Optimizing Treatment Outcome in ART
 
Antagonist or agonist
Antagonist or agonistAntagonist or agonist
Antagonist or agonist
 
LH in Human Reproduction
LH in Human ReproductionLH in Human Reproduction
LH in Human Reproduction
 
Managing Difficult Infertile Patients
Managing Difficult Infertile PatientsManaging Difficult Infertile Patients
Managing Difficult Infertile Patients
 
Individualization
IndividualizationIndividualization
Individualization
 
Enzymes
EnzymesEnzymes
Enzymes
 
C.1 menstrual cycle
C.1   menstrual cycleC.1   menstrual cycle
C.1 menstrual cycle
 
Physiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in laborPhysiology of labor. Anaesthesia in labor
Physiology of labor. Anaesthesia in labor
 
R lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cyclesR lh supplementation to rfsh in gnrh antagonist cycles
R lh supplementation to rfsh in gnrh antagonist cycles
 
Vitrification in IVF
Vitrification in IVFVitrification in IVF
Vitrification in IVF
 
Abortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, mdAbortion & ectopic pregnancy by liza tarca, md
Abortion & ectopic pregnancy by liza tarca, md
 
Tema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bisTema 27 _anticancerosos_bis
Tema 27 _anticancerosos_bis
 
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
 IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha... IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain  Dr. Jyoti Bha...
IVF – ICSI in PCOS DIFFICULTIES AND SOLUTIONS Dr. Sharda Jain Dr. Jyoti Bha...
 
Individualization of Patient Treatment
Individualization of Patient TreatmentIndividualization of Patient Treatment
Individualization of Patient Treatment
 
ICSI
ICSIICSI
ICSI
 
Prognostic models
Prognostic modelsPrognostic models
Prognostic models
 

Similaire à GnRH antagonists

GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda umfrfouda
 
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilBharati Dhorepatil
 
ovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateHesham Al-Inany
 
Medical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulationMedical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulationLifecare Centre
 
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...DelhiGynaecologistForum
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)鋒博 蔡
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine鋒博 蔡
 
複製 New developments in reproductive medicine
複製  New developments in reproductive medicine複製  New developments in reproductive medicine
複製 New developments in reproductive medicinet7260678
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)t7260678
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicinet7260678
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)鋒博 蔡
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine鋒博 蔡
 
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...Candido Tomás
 

Similaire à GnRH antagonists (20)

GnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH AntagonistGnRH Agonist Versus GnRH Antagonist
GnRH Agonist Versus GnRH Antagonist
 
High responders
High respondersHigh responders
High responders
 
Ovarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohssOvarian hyper stimulation syndrome ohss
Ovarian hyper stimulation syndrome ohss
 
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda GnRH antagonist in Ovarian stimulation for   IVF/ET, Prof. Usama M.Fouda
GnRH antagonist in Ovarian stimulation for IVF/ET, Prof. Usama M.Fouda
 
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati DhorepatilPCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 2 - Dr Bharati Dhorepatil
 
ovarian stimulation : a 2018 update
ovarian stimulation : a 2018 updateovarian stimulation : a 2018 update
ovarian stimulation : a 2018 update
 
Subfertility
SubfertilitySubfertility
Subfertility
 
Ovarian drilling
Ovarian drillingOvarian drilling
Ovarian drilling
 
Medical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulationMedical managment of ovarian hyperstimulation
Medical managment of ovarian hyperstimulation
 
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...OVARIAN HYPERSTIMULATION SYNDROME (OHSS)  : Our Experience in 580 IVF Cycles,...
OVARIAN HYPERSTIMULATION SYNDROME (OHSS) : Our Experience in 580 IVF Cycles,...
 
Ohss
OhssOhss
Ohss
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
 
複製 New developments in reproductive medicine
複製  New developments in reproductive medicine複製  New developments in reproductive medicine
複製 New developments in reproductive medicine
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
 
New developments in reproductive medicine (1)
New developments in reproductive medicine (1)New developments in reproductive medicine (1)
New developments in reproductive medicine (1)
 
New developments in reproductive medicine
New developments in reproductive medicineNew developments in reproductive medicine
New developments in reproductive medicine
 
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
To pill or not to pill in GnRa-antagonist protocols Candido Tomás, Ovumia 030...
 
Ivf in pcos
Ivf in pcosIvf in pcos
Ivf in pcos
 

Plus de Hesham Gaber

So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1Hesham Gaber
 
Thromboprophylaxis
ThromboprophylaxisThromboprophylaxis
ThromboprophylaxisHesham Gaber
 
Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism Hesham Gaber
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statisticsHesham Gaber
 
Statistics & infertility
Statistics & infertilityStatistics & infertility
Statistics & infertilityHesham Gaber
 
Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101Hesham Gaber
 
Randomised controlled trials
Randomised controlled trialsRandomised controlled trials
Randomised controlled trialsHesham Gaber
 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeHesham Gaber
 
Management of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal womenManagement of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal womenHesham Gaber
 
Hysteroscopic metroplasty
Hysteroscopic metroplasty Hysteroscopic metroplasty
Hysteroscopic metroplasty Hesham Gaber
 

Plus de Hesham Gaber (20)

Poor
PoorPoor
Poor
 
Infertility
InfertilityInfertility
Infertility
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1
 
So much evidence 1
So much evidence 1So much evidence 1
So much evidence 1
 
Contraception
ContraceptionContraception
Contraception
 
Thromboprophylaxis
ThromboprophylaxisThromboprophylaxis
Thromboprophylaxis
 
Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism Pattern of vitamin d receptor polymorphism
Pattern of vitamin d receptor polymorphism
 
So much evidence
So much evidenceSo much evidence
So much evidence
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcoma
 
Systematic review
Systematic reviewSystematic review
Systematic review
 
Statistics & infertility
Statistics & infertilityStatistics & infertility
Statistics & infertility
 
Research methodology 101
Research methodology 101Research methodology 101
Research methodology 101
 
Randomised controlled trials
Randomised controlled trialsRandomised controlled trials
Randomised controlled trials
 
Paternal age
Paternal agePaternal age
Paternal age
 
Ovarian hyperstimulation syndrome
Ovarian hyperstimulation syndromeOvarian hyperstimulation syndrome
Ovarian hyperstimulation syndrome
 
Management of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal womenManagement of ovarian cysts in postmenopausal women
Management of ovarian cysts in postmenopausal women
 
Male infertility
Male infertilityMale infertility
Male infertility
 
Intersexuality
IntersexualityIntersexuality
Intersexuality
 
Hysteroscopic metroplasty
Hysteroscopic metroplasty Hysteroscopic metroplasty
Hysteroscopic metroplasty
 

Dernier

Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 

Dernier (20)

Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 

GnRH antagonists

  • 1. kasr al ainy school of Medicine Cairo University CHANGING ATTITUDES IN OVARIAN STIMULATION
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. 16 follicles 12 mature oocytes 14 oocytes Extras frozen if good 2 to 3 transferred 9 fertilize normally 5 divide normally 30-40% of couples 4 stop dividing & sperm Typical progression
  • 7. OHSS is the most serious complication of ovulation induction.
  • 8. PROTOCOLS FOR IVF GnRH Antagonist Protocols GnRH Agonist Protocols 225 IU per day (150 IU Europe ) Individualized Dosing of FSH/HMG 250 mg per day antagonist Individualized Dosing of FSH/HMG GnRHa 1.0 mg per day up to 21 days 0.5 mg per day of GnRHa 225 IU per day (150 IU Europe ) Day 6 of FSH/HMG Day of hCG Day 1 of FSH/HMG Day 6 of FSH/HMG Day of hCG 7 – 8 days after estimated ovulation Down regulation Day 2 or 3 of menses Day 1 FSH/HMG
  • 9.
  • 11.
  • 12.
  • 13.
  • 14. WHY: (AL-INANY ET AL, 2010)
  • 15.
  • 16.
  • 18.
  • 19.
  • 21. CPR
  • 23.
  • 24. 3. 0 ampoules less with GnRH antagonists p<0.0 7 FSH requirement
  • 25. 1. 1 less days with antagonists p<0.001 Duration of FSH treatment
  • 26.
  • 27. LH STABILITY: AGONIST VS. ANATGONIST
  • 30. Meta-analysis of clinical pregnancy rate in fixed and flexible protocols for GnRH antagonist protocols Al-Inany et al. 2005
  • 31.
  • 32.
  • 33. BUT NOT ALL DOCTORS WOULD GO FOR ANTAGONIST
  • 34.
  • 35.
  • 36.  
  • 37. OUR RESULTS Parameter Coasting (n = 96) Antagonist (n = 94) P-value Age (years) 30.0 ± 4.9 29.6 ± 4.6 NS Duration of infertility (years) 6.64 ± 4.45 7.07 ± 4.3 NS No. of HMG injections 30.52 ± 8.9 29.94 ± 8.8 NS Days of stimulation 1 9.1 ± 1.5 9.4 ± 1.5 NS Peak oestradiol (pg/ml) 5087 ± 1589 5305 ± 1680 NS Oestradiol on day of HCG (pg/ml) 2605 ± 790 2721 ± 699 NS Range of oestradiol on day of HCG (pg/ml) 1110–4136 1223–4093 NS Day of intervention 2.82 ± 0.97 1.74 ± 0.91 <0.0001 No. of oocytes 14.06 ± 5.20 16.5 ± 7.60 0.02 No. of MII oocytes 11.13 ± 4.60 13.14 ± 6.60 NS No. of fertilized oocytes   7.97 ± 3.80   9.14 ± 4.70 NS No. of high quality embryos   2.21 ± 1.10   2.87 ± 1.20 0.0001 No. of embryos transferred   2.83 ± 0.50   2.79 ± 0.40 NS No. of cryopreserved embryos   4.50 ± 3.93   5.77 ± 4.87 NS Clinical pregnancy (%) 46/96 (47.9) 52/94 (55.3) NS Multiple pregnancy (%) 15/46 (32.6) 17/52 (32.7) NS
  • 38.
  • 39.
  • 41.
  • 42. THANK YOU Dr. Hesham Al-Inany MD, PhD e-mail : hesham@khosoba.com

Notes de l'éditeur

  1. 06/28/11
  2. 06/28/11
  3. 06/28/11
  4. * *
  5. * *
  6. 06/28/11
  7. IBSA Institut Biochimique SA 28/06/11